OnKure Therapeutics, Inc.(OKUR)

Biotechnology · Boulder, CO

$2.49-0.14 (-5.32%)

Delayed quote: Oct 6, 2026, 3:14 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T19:17:56.271Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:17:56.271Z.

Quote observation: 2026-10-06T19:14:14.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 100,835,787
Total debt · period ending 2026-06-30: 926,000
Cash · period ending 2026-06-30: 166,502,000
TTM free cash flow · period ending 2026-06-30: -47,864,000

FMP input reference: 352cae2fe5eed9f02885becd1bbca6bb54c51239af0254a5780fc03f1b1dafbc

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

OKUR EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

OKUR Competitors' EV/FCF Ratio

OKUR

OnKure Therapeutics, Inc.

Current

Market Cap

$100.84M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs OKUR

Market Cap

$102.28M

EV/FCF Ratio

19.43x

TTM Avg

87.97x

3Y Avg

49.68x

5Y Avg

56.25x

ANIX

Anixa Biosciences, Inc.

vs OKUR

Market Cap

$102.40M

EV/FCF Ratio

N/A

TTM Avg

15.12x

3Y Avg

15.12x

5Y Avg

15.12x

KRRO

Korro Bio, Inc.

vs OKUR

Market Cap

$97.99M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs OKUR

Market Cap

$97.71M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLYX

Polaryx Therapeutics, Inc. Common Stock

vs OKUR

Market Cap

$104.67M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Definitive Healthcare Corp.

vs OKUR

Market Cap

$104.72M

EV/FCF Ratio

3.53x

TTM Avg

5.56x

3Y Avg

15.97x

5Y Avg

36.28x

BDTX

Black Diamond Therapeutics, Inc.

vs OKUR

Market Cap

$104.29M

EV/FCF Ratio

N/A

TTM Avg

7.65x

3Y Avg

7.65x

5Y Avg

7.65x

MIST

Milestone Pharmaceuticals Inc.

vs OKUR

Market Cap

$96.21M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CPIX

Cumberland Pharmaceuticals Inc.

vs OKUR

Market Cap

$105.63M

EV/FCF Ratio

N/A

TTM Avg

22.94x

3Y Avg

13.31x

5Y Avg

10.37x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
OnKure Therapeutics, Inc. (OKUR)	$100.84M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.28M	19.43x	87.97x	49.68x	56.25x
Anixa Biosciences, Inc. (ANIX)vs ›	$102.40M	N/A	15.12x	15.12x	15.12x
Korro Bio, Inc. (KRRO)vs ›	$97.99M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$97.71M	N/A	N/A	N/A	N/A
Polaryx Therapeutics, Inc. Common Stock (PLYX)vs ›	$104.67M	N/A	N/A	N/A	N/A
Definitive Healthcare Corp. (DH)vs ›	$104.72M	3.53x	5.56x	15.97x	36.28x
Black Diamond Therapeutics, Inc. (BDTX)vs ›	$104.29M	N/A	7.65x	7.65x	7.65x
Milestone Pharmaceuticals Inc. (MIST)vs ›	$96.21M	N/A	N/A	N/A	N/A
Cumberland Pharmaceuticals Inc. (CPIX)vs ›	$105.63M	N/A	22.94x	13.31x	10.37x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

OKUR EV/FCF Ratio Metrics

OKUR Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics